Efficacy and Safety of Teprotumumab in Thyroid Eye Disease

Thyroid eye disease (TED; also known as thyroid-associated ophthalmopathy) is an autoimmune condition with disabling and disfiguring consequences. Teprotumumab is the first and only medication approved by the United States Food and Drug Administration for the treatment of TED. We review the efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Teo, Honeylen Maryl, Smith, Terry J, Joseph, Shannon S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630371/
https://www.ncbi.nlm.nih.gov/pubmed/34858025
http://dx.doi.org/10.2147/TCRM.S303057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630371/
https://www.ncbi.nlm.nih.gov/pubmed/34858025
http://dx.doi.org/10.2147/TCRM.S303057

Ejemplares similares